Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat

In the this study we have investigated the threshold plasma concentration of lidocaine for reversal of mechanical 'allodynia' in a neuropathic pain model in the rat, defined the concentration-dependent limits of that reversal and compared the acute reversal during intravenous drug infusion with the persistent relief of allodynia assayed 48 h later. Actions of i.v. lidocaine on ipsilateral and contralateral legs were also assessed. Forty rats were sorted into five groups (n = 7-10) and underwent spinal root (L5-6) ligation to produce allodynia, as quantified by a lower force of von Frey hairs at the plantar hindpaw required to elicit paw withdrawal (PWT, paw withdrawal threshold). During surgery, intravenous catheters were placed for programmed lidocaine infusion and in some animals arterial catheters were also inserted for assaying lidocaine blood levels. PWTs were measured in ipsilateral and contralateral paws before and after ligation and during infusions which, beginning at 5 days after surgery, were conducted every other day to incrementing levels (1.1-9.7 microg/ml plasma). Ligation produced allodynia in ipsilateral paws (PWT = 1.22 +/- 0.42 g (+/-SEM)) and in contralateral paws (PWT = 4.99 +/- 0.61 g), both markedly lower than pre-operative control values for either paw (11.31 +/- 0.41 g). The ipsilateral allodynia was partially, but significantly and permanently reversed (to PWT = 6-8 g) after a lidocaine infusion to 2.1 microg/ml in two separate groups (n = 7, 8). Lower concentrations resulted in elevation of PWT during infusion but no sustained relief. The elevation of PWT during infusion at this threshold level among individual animals was positively correlated with the relief measured 48 h later, but higher lidocaine concentrations infused in subsequent dosings could exact no further sustained relief. The residual PWT level, after reversal by threshold lidocaine and greater, was constant for each individual rat tested over the next 14 days but varied substantially among individuals; some were restored to pre-operative PWTs and some were totally unresponsive to drug. Retrospective analysis revealed a significant and unanticipated correlation between the incidence of low pre-operative PWTs (< 10 g) and a lack of sustained reversal of post-operative allodynia by lidocaine. Contralateral allodynia, despite its acute reversal during infusion to 2.1 microg/ml and higher, was not persistently relieved after infusion of lidocaine to any concentration. Repeated infusions to subthreshold levels (<2 microg/ml) did not provide persisting relief of allodynia on either side, and infusions of saline were impotent. These findings show that experimental allodynia results from multiple factors, only some of which are sensitive to lidocaine treatment, and that prolonged reversal of allodynia is limited in extent and likely influenced by pre-existing factors.

[1]  R. Dubner,et al.  Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation , 1991, Brain Research.

[2]  A. Duggan,et al.  Bilaterally enhanced dorsal horn postsynaptic currents in a rat model of peripheral mononeuropathy , 1996, Neuroscience Letters.

[3]  Ronald Melzack,et al.  Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence , 1993, Pain.

[4]  N. Attal,et al.  Behavioural pain-related disorders and contribution of the saphenous nerve in crush and chronic constriction injury of the rat sciatic nerve , 1994, Pain.

[5]  G. R. Arthur,et al.  The Analgesic Response to Intravenous Lidocaine in the Treatment of Neuropathic Pain , 1996, Anesthesia and analgesia.

[6]  M. L. Sotgiu,et al.  Diverse modulation by systemic lidocaine of iontophoretic NMDA and quisqualic acid induced excitations on rat dorsal horn neurons , 1993, Neuroscience Letters.

[7]  C. Woolf,et al.  The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord , 1985, Pain.

[8]  T. Yaksh,et al.  Systemic Lidocaine Blocks Nerve Injury‐induced Hyperalgesia and Nociceptor‐driven Spinal Sensitization in the Rat , 1994, Anesthesiology.

[9]  Patrick D. Wall,et al.  Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction , 1992, Pain.

[10]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[11]  J. Deleo,et al.  Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model , 1993, Brain Research.

[12]  G. Hempelmann,et al.  ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine. Possible impact on the antiarrhythmic action of lidocaine. , 1996, Circulation.

[13]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[14]  T. Narahashi,et al.  Differential properties of tetrodotoxin-sensitive and tetrodotoxin- resistant sodium channels in rat dorsal root ganglion neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  M. L. Sotgiu,et al.  Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord , 1993, Brain Research.

[16]  B. Hille,et al.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reaction , 1977, The Journal of general physiology.

[17]  U. Lindblom,et al.  The effect of systemic tocainide, lidocaine and bupivacaine on nociception in the rat , 1985, Pain.

[18]  M. Rowbotham,et al.  Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia , 1991, Neurology.

[19]  S. A. Raymond,et al.  Susceptibility to lidocaine of impulses in different somatosensory afferent fibers of rat sciatic nerve. , 1997, The Journal of pharmacology and experimental therapeutics.

[20]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.

[21]  A. Cairns,et al.  Differential Slowing and Block of Conduction by Lidocaine in Individual Afferent Myelinated and Unmyelinated Axons , 1984, Anesthesiology.

[22]  L. Sorkin,et al.  Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity , 1996, Pain.

[23]  D. Tanelian,et al.  Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. , 1991, Anesthesiology.

[24]  J. Kastrup,et al.  Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy? , 1987, Pain.

[25]  D. Attwell,et al.  The dependence of the maximum rate of rise of the action potential upstroke on membrane properties , 1981, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[26]  N. Attal,et al.  Further evidence for ‘pain-related’ behaviours in a model of unilateral peripheral mononeuropathy , 1990, Pain.

[27]  G. Strichartz,et al.  The Inhibition of Sodium Currents in Myelinated Nerve by Quaternary Derivatives of Lidocaine , 1973, The Journal of general physiology.

[28]  Ronald Dubner,et al.  A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.

[29]  S L Shafer,et al.  Prolonged Alleviation of Tactile Allodynia by Intravenous Lidocaine in Neuropathic Rats , 1995, Anesthesiology.

[30]  D. Drachman,et al.  Potassium channel blockers potentiate impulse inhibition by local anesthetics. , 1991, Anesthesiology.

[31]  C. Woolf,et al.  Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-d-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics , 1996, Pain.

[32]  G. Strichartz,et al.  Kinetics of local anesthetic inhibition of neuronal sodium currents. pH and hydrophobicity dependence. , 1990, Biophysical journal.

[33]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[34]  G. Strichartz,et al.  Local anesthetics inhibit the G protein-mediated modulation of K+ and Ca++ currents in anterior pituitary cells. , 1999, Molecular pharmacology.

[35]  L. C. Russell,et al.  The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas , 1989, Pain.

[36]  K. Courtney,et al.  The rates of interaction of local anesthetics with sodium channels in nerve. , 1978, The Journal of pharmacology and experimental therapeutics.

[37]  B. Hille,et al.  Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. , 1977, Biophysical journal.

[38]  B. Katzung,et al.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. , 1977, Biochimica et biophysica acta.

[39]  M. A. Rowe,et al.  Subanesthetic concentrations of lidocaine selectively inhibit a nociceptive response in the isolated rat spinal cord , 1995, Pain.

[40]  M. L. Sotgiu,et al.  Different time-courses of i.v. lidocaine effect on ganglionic and spinal units in neuropathic rats. , 1994, Neuroreport.

[41]  K. Bley,et al.  QX-314 inhibits ectopic nerve activity associated with neuropathic pain , 1997, Brain Research.